DOSE-RESPONSE STUDY OF THE ANTI-COAGULANT AND LIPOLYTIC-ACTIVITIES OF HEPARIN IN NORMAL SUBJECTS

被引：32

作者：

ASMAL, AC

LEARY, WP

THANDROYEN, F

BOTHA, J

WATTRUS, S

机构：

来源：

关键词：

D O I：

10.1111/j.1365-2125.1979.tb01000.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：531 / 533

页数：3

共 13 条

[1] BOBERG J, 1964, CLIN CHEM ACTA, V10, P427
[2] BRUNZELL, 1975, BRIT J CLIN PHARMAC, V2
[3] REVERSIBLE ABNORMALITIES IN POSTHEPARIN LIPOLYTIC-ACTIVITY DURING LATE PHASE OF RELEASE IN DIABETES-MELLITUS (POSTHEPARIN LIPOLYTIC-ACTIVITY IN DIABETES)
BRUNZELL, JD
PORTE, D
BIERMAN, EL
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1975, 24 (10): : 1123 - 1137
[4] COLORIMETRIC MICRO-DETERMINATION OF NON-ESTERIFIED FATTY ACIDS IN PLASMA
DUNCOMBE, WG
[J]. CLINICA CHIMICA ACTA, 1964, 9 (02) : 122 - &
[5] EGGSTEIN M, 1974, METHODS ENZYMATIC AN
[6] HAM JM, 1977, HAEMOSTASIS, V6, P26
[7] HEAF, 1977, BRIT J CLIN PHARMAC, V4
[8] DIFFERENCES IN HEPARIN-RELEASED LIPOLYTIC-ACTIVITY IN SUPERFICIAL AND DEEP VEINS OF HUMAN FOREARM
HEAF, DJ
KAIJSER, L
EKLUND, B
CARLSON, LA
[J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1977, 7 (03) : 195 - 199
[9] LANGDELL RD, 1971, THROMBOSIS BLEEDING
[10] LEVINE WG, 1975, PHARMACOLOGICAL BASI